
浏览全部资源
扫码关注微信
川北医学院附属医院中西医结合肛肠科,四川 南充 637000
硕士研究生。研究方向:中西医治疗肛肠疾病。 E-mail:yingchen9701@163.com
教授,硕士生导师。研究方向:中西医治疗肛肠疾病。E-mail:wzj549nc@126.com
收稿:2025-12-16,
修回:2026-04-19,
录用:2026-04-20,
纸质出版:2026-05-15
移动端阅览
陈颖,徐荣,何瑶,等.基于肠道菌群-色氨酸代谢-芳香烃受体轴探讨黄芩汤改善溃疡性结肠炎的作用机制 [J].中国药房,2026,37(09):1173-1179.
CHEN Ying,XU Rong,HE Yao,et al.Mechanism of Huangqin decoction in improving ulcerative colitis based on the gut microbiota-tryptophan metabolism-aryl hydrocarbon receptor axis[J].ZHONGGUO YAOFANG,2026,37(09):1173-1179.
陈颖,徐荣,何瑶,等.基于肠道菌群-色氨酸代谢-芳香烃受体轴探讨黄芩汤改善溃疡性结肠炎的作用机制 [J].中国药房,2026,37(09):1173-1179. DOI: 10.6039/j.issn.1001-0408.2026.09.11.
CHEN Ying,XU Rong,HE Yao,et al.Mechanism of Huangqin decoction in improving ulcerative colitis based on the gut microbiota-tryptophan metabolism-aryl hydrocarbon receptor axis[J].ZHONGGUO YAOFANG,2026,37(09):1173-1179. DOI: 10.6039/j.issn.1001-0408.2026.09.11.
目的
2
探讨黄芩汤通过肠道菌群-色氨酸代谢-芳香烃受体(AhR)轴改善溃疡性结肠炎(UC)的机制。
方法
2
将小鼠随机分为正常组(生理盐水)、模型组(生理盐水)、菌群消耗-模型组(生理盐水)、菌群消耗-黄芩汤组(9.1 g/kg,以生药量计;下同)、黄芩汤组及美沙拉嗪组(阳性对照组,0.4 g/kg),每组6只。通过自由饮用抗菌药物混合液10 d消耗菌群,自由饮用2.5%葡聚糖硫酸钠溶液7 d构建UC模型。造模成功后,各组小鼠灌胃相应药液/生理盐水,每天1次,连续10 d。末次给药后,测定小鼠体重变化比、疾病活动指数(DAI)评分、结肠长度,观察结肠病理学变化,检测血清中白细胞介素6(IL-6)、IL-10、IL-22、肿瘤坏死因子α(TNF-α)含量以及结肠组织中闭合蛋白(Occludin)、闭锁小带蛋白1(ZO-1)、AhR的表达,并对小鼠粪便进行高通量测序和色氨酸靶向代谢组学分析。
结果
2
与模型组比较,黄芩汤组小鼠结肠组织炎症细胞浸润减少,肠黏膜结构恢复;体重变化比、结肠长度、血清中IL-10含量和结肠组织中Occludin、ZO-1、AhR表达水平以及色氨酸代谢物吲哚-3-丙酸(IPA)、
N
-乙酰-5-羟色胺(NAS)、吲哚-3-乙酸(IAA)含量均显著升高/增加(
P
<0.05);DAI评分以及血清中IL-6、TNF-α、IL-22含量和色氨酸代谢物吲
哚-3-乙醇含量均显著降低(
P
<0.05);肠道菌群结构改善,乳杆菌属等有益菌的相对丰度呈升高趋势,大肠埃希氏菌-志贺氏菌属等致病菌的相对丰度呈降低趋势。然而,抗菌药物消耗菌群后,黄芩汤虽能显著升高小鼠粪便中NAS含量,但结肠组织中AhR蛋白表达未同步显著回升。
结论
2
黄芩汤可通过调控肠道菌群,促进IPA、IAA产生,从而激活AhR,进而修复UC小鼠肠黏膜屏障;完整肠道菌群是黄芩汤发挥AhR调控作用的重要前提。
OBJECTIVE
2
To investigate the mechanism of Huangqin decoction in improving ulcerative colitis (UC) through the gut microbiota-tryptophan metabolism-aryl hydrocarbon receptor (AhR) axis.
METHODS
2
Mice were randomly divided into normal group (normal saline), model group (normal saline), microbiota depletion-model group (normal saline), microbiota depletion-Huangqin decoction group (9.1 g/kg, by crude drug, similarly hereinafter), Huangqin decoction group and mesalazine group (positive control group, 0.4 g/kg), with 6 mice in each group. Microbiota depletion was achieved by providing free access to a mixed antibiotics for 10 days. The UC model was induced by administering 2.5% dextran sulfate sodium solution for 7 days. After successful modeling, each treatment group received corresponding drugs or normal saline intragastrically once daily for 10 days. After the final administration, body weight change ratio, disease activity index (DAI) score, and colon length were evaluated; colon pathological changes were observed; serum levels of interleukin-6 (IL-6), IL-10, IL-22, and tumor necrosis factor-α (TNF-α) were measured; the expressions of Occludin, zonula occluden-1 (ZO-1), and AhR in colon tissue were detected; fecal samples were subjected to high-throughput sequencing to analyze targeted tryptophan metabolomics.
RESULTS
2
Compared with the model group, Huangqin decoction group showed reduced infiltration of inflammatory cells in the colon tissue and restoration of the intestinal mucosal structure. Body weight change ratio, colon length, serum content of IL-10, the expressions of Occludin, ZO-1 and AhR in colon
tissue and the contents of tryptophan metabolites indole-3-propionic acid (IPA),
N
-acetylserotonin (NAS) and indole-3-acetic acid (IAA) were all significantly increased (
P
<0.05); DAI score, serum levels of IL-6, TNF-α, and IL-22 and the content of tryptophan metabolite indole-3-ethanol were significantly decreased (
P
<0.05); gut microbiota structure was improved, with increased relative abundances of beneficial bacteria such as
Lactobacillus
, and decreased relative abundances of pathogenic bacteria such as
Escherichia-Shigella
. However, after antibiotic-induced microbiota depletion, although Huangqin decoction significantly increased the content of NAS in the feces of mice, the expression of AhR protein in colon tissue did not increase concurrently.
CONCLUSIONS
2
Huangqin decoction can repair the intestinal mucosal barrier in UC mice by regulating the gut microbiota and promoting the production of IPA and IAA, thereby activating AhR. This suggests that an intact gut microbiota is an important prerequisite for Huangqin decoction to exert its AhR-regulating effects.
中国中西医结合学会 . 溃疡性结肠炎中西医结合诊疗指南 [J ] . 中国中西医结合杂志 , 2024 , 44 ( 9 ): 1029 - 1035 .
何琼 , 李建栋 . 炎症性肠病流行病学研究进展 [J ] . 实用医学杂志 , 2019 , 35 ( 18 ): 2962 - 2966 .
JAIRATH V , COHEN R D , LOFTUS E V , et al . Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis [J ] . BMC Gastroenterol , 2022 , 22 ( 1 ): 501 .
WU J W , WEI Z H , CHENG P , et al . Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis [J ] . Theranostics , 2020 , 10 ( 23 ): 10665 - 10679 .
YU S Y , SUN Y B , SHAO X Y , et al . Leaky gut in IBD:intestinal barrier-gut microbiota interaction [J ] . J Microbiol Biotechnol , 2022 , 32 ( 7 ): 825 - 834 .
刘雨翀 , 刘同亭 . 中医药修复湿热型溃疡性结肠炎肠道黏膜屏障的研究进展 [J ] . 光明中医 , 2023 ( 5 ): 856 - 859 .
YU K , MA Y H , ZHANG Z C , et al . AhR activation protects intestinal epithelial barrier function through regulation of Par-6 [J ] . J Mol Histol , 2018 , 49 ( 5 ): 449 - 458 .
PEI T C , LI W , ZHOU Z Y , et al . The relationship between tryptophan metabolism and gut microbiota:interaction mechanism and potential effects in infection treatment [J ] . Microbiol Res , 2025 , 298 : 128211 .
姜洪宇 , 陈萌 , 关露春 , 等 . 从“肠道黏膜屏障完整性”角度探讨黄芩汤治疗溃疡性结肠炎的机制 [J ] . 中华中医药学刊 , 2024 , 42 ( 3 ): 113 - 118 .
亓照耀 , 刘金存 , 许源慧 , 等 . 两种给药途径对联合抗生素建立伪无菌大鼠模型比较 [J ] . 中国微生态学杂志 , 2023 , 35 ( 10 ): 1123 - 1129 .
LIU X , QIU X , YANG Y , et al . Alteration of gut micro- biome and metabolome by Clostridium butyricum can repair the intestinal dysbiosis caused by antibiotics in mice [J ] . iScience , 2023 , 26 ( 3 ): 106190 .
何旭东 , 宋成竹 , 倪皓雨 , 等 . 苦参醇F调节肠道菌群及免疫应答对溃疡性结肠炎小鼠的改善作用机制研究 [J ] . 中国药房 , 2024 , 35 ( 17 ): 2088 - 2095 .
钟焕英 , 刘礼剑 , 卫家润 , 等 . 中药对微小RNA调控溃疡性结肠炎相关信号通路的干预作用研究进展 [J ] . 中国药房 , 2023 , 34 ( 17 ): 2167 - 2171 .
马琳 , 范荣珍 , 李炜 , 等 . 溃疡性结肠炎动物模型及评价指标 [J ] . 神经药理学报 , 2025 , 15 ( 4 ): 8 - 16 .
王小天 , 彪雅宁 , 张一昕 , 等 . 基于“肠道菌-胆汁酸”轴探讨燮理汤治疗溃疡性结肠炎小鼠的作用机制 [J ] . 中国实验方剂学杂志 , 2025 , 31 ( 1 ): 30 - 38 .
黄静 , 廖艳花 , 莫昕莹 , 等 . 紫云英苷调节肠道菌群缓解小鼠溃疡性结肠炎的作用机制 [J ] . 中国药房 , 2025 , 36 ( 14 ): 1709 - 1716 .
潘思敏 , 白晓辉 , 陈雪如 , 等 . 基于肠道菌群和胆汁酸代谢探讨清肠消澼饮治疗葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠模型的作用机制 [J ] . 中药新药与临床药理 , 2024 , 35 ( 12 ): 1842 - 1850 .
WU F , WANG Y , MAI Z P , et al . Human intestinal fungus Clavispora lusitaniae attenuates colitis through pyruvate decarboxylase-derived indole-3-ethanol [J ] . Nat Commun , 2025 , 16 : 9980 .
PROIETTI E , PAUWELS R W M , DE VRIES A C , et al . Modulation of indoleamine 2,3-dioxygenase 1 during inflammatory bowel disease activity in humans and mice [J ] . Int J Tryptophan Res , 2023 , 16 : 11786469231153109 .
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621